// App-Quantinova.ai

2103-284 : IMPACT OF PROTON PUMP INHIBITOR ON ONE-YEAR CLINICAL OUTCOMES IN PATIENTS UNDERWENT PERCUTANEOUS CORONARY INTERVENTION ACCORDING TO DUAL VERSUS TRIPLE ANTIPLATELET AGENTS

Researchers

Presenter

  • Sang-Ho Park

Principal Investigators

  • Seung-Woon Rha

  • Woong Jeon

  • Jin oh Na

  • Cheol Ung Choi

  • Dongkyu Jin

  • Byoung Geol Choi

  • Se Yeon Choi

  • Shaopeng Xu

  • Harris Ngow Abdullah

  • Jae Joong Lee

  • Sunki Lee

  • Ji Bak Kim

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Ischemic stroke

  • Myocardial infarction

  • Dyslipidemia

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • Alpha-tubulin N-acetyltransferase 1

  • Dopamine transporter

Drug/Treatment

  • aspirin + clopidogrel

  • cilostazol

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved